Medicinal Usage of Cannabis and Cannabinoids
Editat de Victor R. Preedy, Vinood B. Patel, Colin R Martinen Limba Engleză Hardback – 6 sep 2023
Approx.572 pages
Preț: 1152.86 lei
Preț vechi: 1497.94 lei
-23% Nou
Puncte Express: 1729
Preț estimativ în valută:
220.63€ • 229.18$ • 183.27£
220.63€ • 229.18$ • 183.27£
Carte disponibilă
Livrare economică 06-20 ianuarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780323900362
ISBN-10: 0323900364
Pagini: 600
Dimensiuni: 216 x 276 x 37 mm
Greutate: 1.92 kg
Editura: ELSEVIER SCIENCE
ISBN-10: 0323900364
Pagini: 600
Dimensiuni: 216 x 276 x 37 mm
Greutate: 1.92 kg
Editura: ELSEVIER SCIENCE
V-ar putea interesa
-
-18%Preț: 1189.62 lei1452.98 lei -
-22%Preț: 543.25 lei699.63 lei -
-23%Preț: 914.38 lei1182.64 lei -
Children Mourning, Mourning ChildrenKenneth J. Doka-27%Preț: 812.19 lei1112.19 lei -
-14%Preț: 1315.07 lei1523.48 lei -
Lo Psicotico. Donde Se Pierde La RealidadEl PensadorPreț: 205.03 lei -
El Psicoanalista y El Ascenso de Los Angeles CaidosHugo a. Ocando RinconPreț: 248.49 lei -
Grandma Mary Says Things HappenGladys Noll Alvarez LiswPreț: 126.66 lei -
Preț: 66.37 lei -
Healing the Invisible Wounds of the HeartWendy J. MahillPreț: 138.59 lei -
Knotted TonguesBenson BobrickPreț: 89.37 lei -
Open the Door Please?Celeste Ennis BicknellPreț: 97.51 lei -
Preț: 80.96 lei -
General Methods in Biomarker Research and their ApplicationsVictor R. Preedy-5%Preț: 3280.96 lei3453.64 lei -
Preț: 121.67 lei
Public țintă
Researchers in neuroscience and the biomedical sciences; behavioral neuroscientistsCuprins
Preface
I. Setting the scene and introductory chapters
1. How medical cannabis may influence the future of medicine Martha Rosenthal
2. Medical cannabis and cannabinoids: how best to extract components from plant material Roberta Costi
3. Medicinal usage of cannabis and its impact on mental health among cancer patients and survivors Nicolas Hernandez Ortega, Ye Chen, Jessica Y. Islam, Diane Rodriguez, Marlene Camacho-Rivera and Denise Christina Vidot
4. Cannabis sativa as a traditional phytomedicine: a new narrative covering different countries Md Nasir Ahmed, Tridib Paul, Md. Nur Kabidul Azam, Rownak Jahan and Mohammed Rahmatullah
5. Medical use of cannabis in the middle east Bader Hamza Shirah, Mohammed Ahmed and Ruba Saleh
6. What medicinal cannabis is used for: a focus on Canada Dean T. Eurich, Cerina Lee and Jason Dyck
7. New York perspectives of medical cannabis laboratory analysis Lingyun Li, Stacey Chmura, Christopher Judd and Bryan C. Duffy
8. Potential roles of epigenetic memory on the quality of clonal cannabis plants: Content and profile of secondary metabolites Mohsen Hesami and Max Jones
9. Aberrant use of medicinal cannabis: theoretical and empirical considerations Daniel Feingold
10. Profile of older users of medical cannabis and cannabinoids Joshua Brown
11. Use of cannabidiol oil by caregivers: a focus on Alzheimer's disease Magdalena Leszko
12. Medicinal use of cannabis: adverse events as a balanced perspective Giada Crescioli, Valentina Maggini, Fabio Firenzuoli, Alfredo Vannacci and Niccolo Lombardi
II. Physiological aspects and metabolic aspects
13. Physiopathology and use of cannabinoids for fibrotic diseases Carmen del Rio and E. Munoz
14. Cannabinoids in inflammation and atherosclerosis Leonor Thomson, Edward Moreira-Bahnson and Bruno Musetti
15. Targeting the CB(2) receptors and other endocannabinoid elements to delay disease progression in cardiovascular diseases Shreesh Ojha
16. BMI in cannabis users: regulation, mechanisms and public health impact Thomas Clark
III. Neurological, psychological and behavioural aspects
17. Neuroprotection by cannabis related products, cannabidiol and cannabigerol, and associated mechanisms of action Carolina Echeverry Sr., Jimena Fagetti, Miguel Reyes-Parada and Cecilia Scorza
18. Cannabis terpenes as neuroprotective agents: a focus on alpha-bisabolol John Staton Laws, Srijan Shrestha and Scott D. Smid
19. Cannabidiol in medicinal usage of stress: modelling investigations into cocaine M. Julia García-Fuster and Olga Valverde
20. Medicinal cannabis and neurocognition impairment Caroline MacCallum, April Christiansen, Lindsay Lo, Carly Pistawka, Michael Boivin and Melissa Snider-Adler
21. Genetic models of audiogenic seizures: what they are and how cannabinoids and Cannabis-derived compounds can be used to alleviate their symptoms - an updated narrative Norberto Garcia-Cairasco
22. Addressing the validity of cannabinoid therapy as an option for the treatment of substance use disorder Rose Chesworth, Erin McLemon and Tim Karl
IV. Pharmacological and cellular aspects
23. Cannabidiolic acid (CBDA), features and profiles: anti-hyperalgesic effects G. Singh, Katja Linher-Melville and Raphael Mechoulam
24. Cannabis-drug interactions: implications for medicinal cannabis use Fran Gengo, Anna Mattle and Christopher Ralyea
25. Cannabinoid receptor subtype 2 (CB2R): features and targets for medical applications Marialessandra Contino, Carmen Abate, Nicola Antonio Colabufo, Francesco Leonetti and Angela Stefanachi
26. Medical use of cannabidiol and impact on cancer cell viability Kent E. Chair and Wesley Raup-Konsavage
27. Anti-inflammatory and antioxidant and immunomodulatory effects of phytocannabinoid β‑caryophyllene: A mechanistic overview Vafa Baradaran Rahimi, Arghavan Memarzia and Prof. Vahid Reza Askari
V. Symptom Control and Medicinal Uses
28. Cancer patients and providers: Attitudes and beliefs of cannabis and cannabinoids use as a treatment Kimberson Tanco
29. CBD (cannabidiol) use in breast cancer chemotherapy Ana I. Torres-Suarez, Ana Isabel Fraguas-Sánchez and Ana Fernández-Carballido
30. Sleep: cannabis and cannabinoids use Eric Murillo-Rodríguez
31. Cannabis and cannabis related products and their uses in aiding sexual health of men and women Lynnette Nathalie Lyzwinski
32. Symptom control in palliative care settings: The role of cannabis-based medicines Maximillian Stevenson and Leah Sera
33. Cannabidiol (CBD) Use in Fragile X Spectrum Disorders Devon Johnson and Randi J. Hagerman
34. Hempseed (Cannabis sativa) and ameliorative effects in hypercholesterolemia NAVEEN KAUSHAL
35. Benzodiazepines and cannabis use Chad Alexander Purcell
36. Features of (+)-trans-cannabidiol-2-hydroxy pentyland applications to disease: a focus on usage in diabetic nephropathy E. Munoz, Matthias Winkler, Marcus Goetz and Isabel Gonzalez Mariscal
37. Medical use of cannabis: applications to Tourette syndrome Kirsten R. Müller-Vahl and Natalia Szejko
38. Cannabinoids and their use in chronic non-cancer pain: a new narrative review Stanley Sau-Ching Wong and Chi Wai Cheung
39. Endometriosis: features and potential role of medical cannabis Mike Armour and Justin Sinclair
40. Cannabis usage for Crohn's disease and ulcerative colitis: a narrative Joseph Feuerstein and Rajsavi Anand
41. Medical cannabis and use in migraine Jessica Jiang and Alasdair M. Barr
42. Cannabidiol (CBD ) and potential in medicinal use in rheumatoid arthritis Torsten Lowin
43. Role of Cannabinoids in Glaucoma: Lowering Intraocular Pressure or Neuroprotection Ujendra Kumar, Sneha Singh and Rishi Somvanshi
44. Medicinal potential of anandamide as a representative endocannabinoid and its effect at the cellular level in skin Adrianna Maria Piasek and Anna Sobiepanek
VI. Resources
45. Medical Cannabis and Resources Rajkumar Rajendram
I. Setting the scene and introductory chapters
1. How medical cannabis may influence the future of medicine Martha Rosenthal
2. Medical cannabis and cannabinoids: how best to extract components from plant material Roberta Costi
3. Medicinal usage of cannabis and its impact on mental health among cancer patients and survivors Nicolas Hernandez Ortega, Ye Chen, Jessica Y. Islam, Diane Rodriguez, Marlene Camacho-Rivera and Denise Christina Vidot
4. Cannabis sativa as a traditional phytomedicine: a new narrative covering different countries Md Nasir Ahmed, Tridib Paul, Md. Nur Kabidul Azam, Rownak Jahan and Mohammed Rahmatullah
5. Medical use of cannabis in the middle east Bader Hamza Shirah, Mohammed Ahmed and Ruba Saleh
6. What medicinal cannabis is used for: a focus on Canada Dean T. Eurich, Cerina Lee and Jason Dyck
7. New York perspectives of medical cannabis laboratory analysis Lingyun Li, Stacey Chmura, Christopher Judd and Bryan C. Duffy
8. Potential roles of epigenetic memory on the quality of clonal cannabis plants: Content and profile of secondary metabolites Mohsen Hesami and Max Jones
9. Aberrant use of medicinal cannabis: theoretical and empirical considerations Daniel Feingold
10. Profile of older users of medical cannabis and cannabinoids Joshua Brown
11. Use of cannabidiol oil by caregivers: a focus on Alzheimer's disease Magdalena Leszko
12. Medicinal use of cannabis: adverse events as a balanced perspective Giada Crescioli, Valentina Maggini, Fabio Firenzuoli, Alfredo Vannacci and Niccolo Lombardi
II. Physiological aspects and metabolic aspects
13. Physiopathology and use of cannabinoids for fibrotic diseases Carmen del Rio and E. Munoz
14. Cannabinoids in inflammation and atherosclerosis Leonor Thomson, Edward Moreira-Bahnson and Bruno Musetti
15. Targeting the CB(2) receptors and other endocannabinoid elements to delay disease progression in cardiovascular diseases Shreesh Ojha
16. BMI in cannabis users: regulation, mechanisms and public health impact Thomas Clark
III. Neurological, psychological and behavioural aspects
17. Neuroprotection by cannabis related products, cannabidiol and cannabigerol, and associated mechanisms of action Carolina Echeverry Sr., Jimena Fagetti, Miguel Reyes-Parada and Cecilia Scorza
18. Cannabis terpenes as neuroprotective agents: a focus on alpha-bisabolol John Staton Laws, Srijan Shrestha and Scott D. Smid
19. Cannabidiol in medicinal usage of stress: modelling investigations into cocaine M. Julia García-Fuster and Olga Valverde
20. Medicinal cannabis and neurocognition impairment Caroline MacCallum, April Christiansen, Lindsay Lo, Carly Pistawka, Michael Boivin and Melissa Snider-Adler
21. Genetic models of audiogenic seizures: what they are and how cannabinoids and Cannabis-derived compounds can be used to alleviate their symptoms - an updated narrative Norberto Garcia-Cairasco
22. Addressing the validity of cannabinoid therapy as an option for the treatment of substance use disorder Rose Chesworth, Erin McLemon and Tim Karl
IV. Pharmacological and cellular aspects
23. Cannabidiolic acid (CBDA), features and profiles: anti-hyperalgesic effects G. Singh, Katja Linher-Melville and Raphael Mechoulam
24. Cannabis-drug interactions: implications for medicinal cannabis use Fran Gengo, Anna Mattle and Christopher Ralyea
25. Cannabinoid receptor subtype 2 (CB2R): features and targets for medical applications Marialessandra Contino, Carmen Abate, Nicola Antonio Colabufo, Francesco Leonetti and Angela Stefanachi
26. Medical use of cannabidiol and impact on cancer cell viability Kent E. Chair and Wesley Raup-Konsavage
27. Anti-inflammatory and antioxidant and immunomodulatory effects of phytocannabinoid β‑caryophyllene: A mechanistic overview Vafa Baradaran Rahimi, Arghavan Memarzia and Prof. Vahid Reza Askari
V. Symptom Control and Medicinal Uses
28. Cancer patients and providers: Attitudes and beliefs of cannabis and cannabinoids use as a treatment Kimberson Tanco
29. CBD (cannabidiol) use in breast cancer chemotherapy Ana I. Torres-Suarez, Ana Isabel Fraguas-Sánchez and Ana Fernández-Carballido
30. Sleep: cannabis and cannabinoids use Eric Murillo-Rodríguez
31. Cannabis and cannabis related products and their uses in aiding sexual health of men and women Lynnette Nathalie Lyzwinski
32. Symptom control in palliative care settings: The role of cannabis-based medicines Maximillian Stevenson and Leah Sera
33. Cannabidiol (CBD) Use in Fragile X Spectrum Disorders Devon Johnson and Randi J. Hagerman
34. Hempseed (Cannabis sativa) and ameliorative effects in hypercholesterolemia NAVEEN KAUSHAL
35. Benzodiazepines and cannabis use Chad Alexander Purcell
36. Features of (+)-trans-cannabidiol-2-hydroxy pentyland applications to disease: a focus on usage in diabetic nephropathy E. Munoz, Matthias Winkler, Marcus Goetz and Isabel Gonzalez Mariscal
37. Medical use of cannabis: applications to Tourette syndrome Kirsten R. Müller-Vahl and Natalia Szejko
38. Cannabinoids and their use in chronic non-cancer pain: a new narrative review Stanley Sau-Ching Wong and Chi Wai Cheung
39. Endometriosis: features and potential role of medical cannabis Mike Armour and Justin Sinclair
40. Cannabis usage for Crohn's disease and ulcerative colitis: a narrative Joseph Feuerstein and Rajsavi Anand
41. Medical cannabis and use in migraine Jessica Jiang and Alasdair M. Barr
42. Cannabidiol (CBD ) and potential in medicinal use in rheumatoid arthritis Torsten Lowin
43. Role of Cannabinoids in Glaucoma: Lowering Intraocular Pressure or Neuroprotection Ujendra Kumar, Sneha Singh and Rishi Somvanshi
44. Medicinal potential of anandamide as a representative endocannabinoid and its effect at the cellular level in skin Adrianna Maria Piasek and Anna Sobiepanek
VI. Resources
45. Medical Cannabis and Resources Rajkumar Rajendram